Table 2 Comparison of treatment times with the conventional jet nebuliser and the PARI eFlow® rapid; n = 70 patients
From: Lung function in adult patients with cystic fibrosis after using the eFlow® rapid for one year
Nebulised medication | Jet nebuliser | eFlow® rapid |
|---|---|---|
Total inhalation time (min/d) | 31.3 (21.4) | 10.2 (8.3) |
Tobramycin (300 mg/5 ml) | 24.3 (11.9) | 8.4 (4.8) |
Colistine (79 mg/3 ml) | 18.8 (8.7) | 6.4 (2.1) |
Dornase alpha (2.5 mg/2.5 ml) | 15.3 (8.1) | 5.4 (4.2) |